Premier Perspectives The blog for insider insights in clinical development Medical and Regulatory Affairs ANDA or 505(b)(2): Choosing the Right Abbreviated Approval Pathway for Your Drug By Kristi Miller June 29, 2021 Featured Posts Study Design Compensating for the Unknown: 3 Keys to Implementing a Successful Decentralized Clinical Trial By Kristi Miller May 13, 2021 Study Design Establishing Competitive Advantage in Dermatology Trials: Critical Study Design and Operational Considerations for a New Age By Kristi Miller January 29, 2021 1 ×
